Sponsor:
M.D. Anderson Cancer Center
Code:
NCT00539162
Conditions
Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 50 - 70+
Healthy Volunteers: Accepted
Interventions
Questionnaire
Brief summary:
Conditions
Ovarian Cancer
Study ID
NCT00539162
Start date
Jul 2, 2001
Status verified date
Apr, 2026
Completion date
Nov 30, 2028
Anticipated
Primary completion date
Nov 30, 2028
Anticipated
Eligibility Criteria
Sex: Female
Age: 50 - 70+
Healthy Volunteers: Accepted
Enrollment
8000 participants
Anticipated
Intervention Model
Single group
Primary purpose
Screening
Arms
experimental: CA 125 Analysis
Interventions
Questionnaire
Primary outcome measure
Central contacts
Study Coordinator MD Anderson
713-563-6728Locations
Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine
Recruiting
Miami, Florida, United States, 33136
Principal Investigator:
Brian Slomovitz, MD
John Stoddard Cancer Center
Recruiting
Des Moines, Iowa, United States, 50309
University of Minnesota
Recruiting
Minneapolis, Minnesota, United States, 55454
Carol G. Simon Cancer Center / Atlantic Health
Recruiting
Morristown, New Jersey, United States, 07962
University of Rochester Medical Center
Recruiting
Rochester, New York, United States, 14642
University of Oklahoma Health Sciences Center
Recruiting
Oklahoma City, Oklahoma, United States, 73104
Women's and Infant's Hospital
Recruiting
Providence, Rhode Island, United States, 02905
University of Texas MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Principal Investigator:
Denise H. Nebgen, MD, PHD, MD, PHD
Women's Hospital of Texas, Obstetrics and Gynecology Associates (OGA)
Recruiting
Houston, Texas, United States, 77054
UT Health Science Center San Antonio
Recruiting
San Antonio, Texas, United States, 78229
Sponsor
M.D. Anderson Cancer Center
Last update posted
May 6, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-06.